Alexium International Group Limited · ASX:AJX
Alexium International — FY2021 Earnings Presentation
18 slides from Alexium International's earnings presentation, Aug 27, 2021
Slide 1: Alexium International Group Limited FY2021 Full Year Results
ALEXIUM INTERNATIONAL GROUP LIMITED FY2021 Full Year Results 27 August 2021 ABN 91 064 820 408 PRESENTED IN US DOLLARS
Slide 2: Disclaimer
Disclaimer To the maximum extent permitted by law, the information contained in this presentation is given without any liability whatsoever being accepted by Alexium International Group Limited (Alexium) or any of its related entities or their respective directors or officers, employees, advisors an
Slide 3: FY2021 Review
ALEXIUM FY2021 REVIEW
Slide 4: Company Overview
Company Overview Advanced materials provider for thermal management and flame retardant applications Performance-driven products developed with environmentally-friendly materials Innovator of technology platforms backed by granted/pending patents that secure the Company’s position in key marke
Slide 5: Company Overview
Company Overview Building from an initial set of three products, over the past few years Alexium has significantly expanded its product portfolio to five platforms Two new platforms (highlighted in yellow in the diagram) were introduced this year ADDRESSABLE MARKETS Mattress & Top of Bed FR Sock
Slide 6: Financial Snapshot
Financial Snapshot Continued Improvements versus prior year Revenue Growth Gross Margin Operating Expenses 19.7% FY2020 FY2021 FY2020 FY2021 Revenue growth from new customers and Decrease due to product mix, H2 gross margin Headcount and travel expenses down, offset by Total Mattress Cooling System
Slide 7: Financial Snapshot (cont.)
Financial Snapshot (cont.) Deliberate and systematic changes throughout the company drive conclusive results Strong customer H1 impacted by product demand in H2 mix Operating Expenses normalising H2 benefit from improved margins/mix and stable expense All values in USD and thousands unless otherwise
Slide 8: COVID-19 Impact
COVID-19 Impact Market Dynamics • Consumer demand has been strong in Alexium’s core market – bedding, and Alexium has improved its supply position with major retail and online brands • Supply chain disruptions in other markets have negatively impacted Alexium’s commercial activities for new product
Slide 9: FY2021 in Review
FY2021 in Review Successes YoY Revenue growth of 20% Growth driven by greater market penetration in thermal management products for bedding applications Significant share of growth is PCM applications to foam (20% of total FY2021 revenue) Expansion of Product Portfolio Two new product line
Slide 10: FY2022 Outlook
ALEXIUM FY2022 OUTLOOK
Slide 11: FY2022: Pivotal Year for Alexium's Growth
FY2022: Pivotal Year for Alexium’s Growth Culmination of FY2018 – FY2021 Technical & Commercial Developments REVENUE DRIVERS Total mattress cooling system full commercialization – Ramp begun in 4Q FY2021, full rate in 1H FY2022 Increased Continued market penetration for BioCool™ products – First sal
Slide 12: Key Milestones for FY2022
Key Milestones for FY2022 Optimization of FR NyCo Broader market penetration manufacturing process and of BioCool™ products in submission for military testing & bedding market evaluation Major customer has fully Complete commercialisation commercialized mattresses 1H 2H of Alexiflam® NF for FR Sock
Slide 13: Financial Results
FINANCIAL RESULTS
Slide 14: Profit & Loss Statement
Profit & Loss Statement • Increased revenue from a combination of new products and full run FY21 FY20 (USD) (USD) Change % Change rates year over year Sales Revenue 7,276 6,079 1,198 19.7% Cost of Goods Sold (4,634) (3,766) (869) 23.1% • Although down 170BPS for the year, gross margin in H2 improved
Slide 15: Cash Flow Statement
Cash Flow Statement FY 21 FY 20 USD USD • Operating Activities Cash flow from operating activities • Cash collections increased with increased revenue, no collection issues Receipts from customers and other income 7,042 6,422 • Payments for raw materials and manufacturing flat versus prior year Paym
Slide 16: Balance Sheet
Balance Sheet • Working Capital • A/R all current and a level higher than same period last year due to increased sales • Inventory and A/P levels up with increased activity to support business • Non-Current Assets • Minimal capex requirements • Majority of intellectual property assets are placed in
Slide 17: Appendix
APPENDIX
Slide 18: Non-GAAP Financial Measure Reconciliation
Non-GAAP Financial Measure Reconciliation Reconciliation of Operating EBITDA (non-GAAP financial measure) to statutory Net Profit/(Loss) FY21 FY20 (USD) (USD) Net Loss for the period (1,445) (6,125) The consolidated financial statements of the Group are general purpose financial Add statements which
Alexium International Group — FY2021 Earnings Presentation on 6ix